Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Non-Current Liabilities (2023 - 2024)

BioScience Health Innovations (BHIC) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $10947.0 as the latest value for Q3 2024.

  • Quarterly Total Non-Current Liabilities rose 36.29% to $10947.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $10947.0 through Sep 2024, up 36.29% year-over-year, with the annual reading at $13074.0 for FY2023, 280.61% up from the prior year.
  • Total Non-Current Liabilities for Q3 2024 was $10947.0 at BioScience Health Innovations, up from $9011.0 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $15235.0 in Q1 2023, with the low at $901.0 in Q2 2023.